Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors

		Phase:		Phase 2

		Treatment ID#:		1089

		Age Group:		Pediatric Only

		Min Karnofsky Score:		50: Requires considerable assistance and frequent medical care

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Atypical Teratoid/Rhabdoid Tumor

		Last Updated:		11/21/2005

		Tumor Types:		Pediatric Brain Tumors


		Comments:		The prognosis of children with CNS Atypical Teratoid/Rhabdoid Tumors (AT/RT) is poor. This study will determine the effectiveness of chemotherapy, intrathecal chemotherapy, and conformal radiation therapy for children with AT/RTs.

		Treatment Type:		Chemotherapy Radiation

		Contact:		Jack van Hoff MD Yale Comprehensive Cancer Center New Haven, CT 06520-8064 USA Phone: 203-785-4640 Fax: E-mail: jack.vanhoff@yale.edu Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By